Insider Trading June 12, 2026 10:04 PM

Procore Chairman's Strategic Share Disposition and Trust-Level Collar Transactions

Craig Courtemanche Jr. executes a $2.5 million sale via 10b5-1 plan while family trusts engage in complex derivative structures, set against a backdrop of mixed Q1 earnings and valuation discussions.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
PCOR

Procore Technologies Chairman Craig F. Courtemanche Jr. recently executed a significant divestiture of company stock, selling approximately $2.5 million worth of shares on June 10, 2026. These transactions were facilitated through a pre-established 10b5-1 trading plan, a mechanism designed to manage insider trading in compliance with regulatory standards. The sale occurred while the stock was trading near its 52-week low, reflecting a substantial decline from its previous highs. Concurrently, family trusts associated with the Chairman engaged in revolving loan and collar transactions involving 1.7 million shares, highlighting complex wealth management strategies within the broader context of Procore's recent financial reporting and market performance.

Procore Chairman's Strategic Share Disposition and Trust-Level Collar Transactions
PCOR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Chairman Craig Courtemanche Jr. sold approximately $2.5 million in shares via a 10b5-1 plan on June 10, 2026, while simultaneously exercising stock options to acquire 56,122 shares.
  • Family trusts associated with the Chairman entered into complex revolving loan and collar transactions involving 1.7 million shares to secure liquidity, utilizing European call and put options with expiration dates in 2029.
  • Procore reported mixed Q1 2026 earnings with a revenue beat of $359.28 million against expectations of $352.82 million, but an EPS miss of $0.34 versus the forecast of $0.36, leading to varied analyst sentiment.

Craig F. Courtemanche Jr., serving as the Chairman of the Board at Procore Technologies, Inc. (NASDAQ: PCOR), has executed a substantial divestiture of the company's common stock. The transactions, which totaled approximately $2,533,544, were carried out on June 10, 2026. This sale activity took place while the stock was trading at $42.36, a price point that sits close to its 52-week low of $40.74 and represents a significant depreciation from its 52-week high of $82.31.

The specific mechanics of the sale involved two distinct tranches of shares. The first tranche consisted of 13,701 shares, which were sold at prices ranging from $44.01 to $44.98, resulting in a weighted average price of $44.69 per share. A subsequent sale involved 42,421 shares, executed at prices between $45.02 and $45.65, with a weighted average price of $45.29 per share. These transactions were conducted pursuant to a 10b5-1 trading plan that was originally established on December 9, 2025. This type of plan allows insiders to pre-schedule trades to avoid accusations of trading on material non-public information.

Analysis from InvestingPro suggests that the stock may currently be undervalued, noting that shares have declined by 43% over the past six months. The analysis highlights the company's strong financial position, pointing to gross profit margins nearing 80% and a balance sheet that holds more cash than debt. However, the market context remains complex, with investor sentiment reflecting concerns over recent earnings performance.

It is important to note the acquisition activity that preceded the sales. On the same day, June 10, 2026, Mr. Courtemanche Jr. acquired 56,122 shares of common stock through the exercise of stock options. These options were exercised at a price of $2.42 per share, totaling $135,815. The options had vested in 60 equal monthly installments beginning on February 5, 2016. Following these combined transactions, Mr. Courtemanche Jr. directly holds 919,704 shares of Procore Technologies common stock and 224,488 stock options.

Separately, on June 12, 2026, the Craig F. Courtemanche and Hillary Courtemanche Family Trust and the Courtemanche 2021 Irrevocable Trust, collectively referred to as the Holders, entered into revolving loan and collar transactions with an unaffiliated bank for general liquidity purposes. These transactions involved writing European call options with an exercise price of $60.9986 per share and purchasing European put options with an exercise price of $37.5716 per share, relating to an aggregate of 1,700,000 shares of common stock. The underlying shares were pledged to the bank to secure the Holders' obligations. No premium was exchanged for either the call or put options. The transactions are divided into 10 equal components with expiration dates ranging from June 1, 2029, to June 14, 2029. The Holders generally retained voting and dividend rights over the pledged shares, subject to sharing the economic benefit of any dividends with the bank.

Regarding indirect ownership, Mr. Courtemanche Jr. holds Procore Technologies common stock through various trusts. These include 2,692,461 shares held by the Craig F. Courtemanche and Hillary Courtemanche Family Trust, 1,155,480 shares by the Courtemanche 2021 Irrevocable Trust, and 527,349 shares by The Courtemanche 2016 Irrevocable Trust. An additional 23,736 shares are held by his spouse.

In the broader context of Procore's recent financial reporting, the company reported its first-quarter 2026 earnings, revealing a mixed performance. The company achieved revenue of $359.28 million, surpassing the expected $352.82 million. However, earnings per share (EPS) came in at $0.34, missing the forecast of $0.36. This revenue beat was accompanied by a decline in the stock price, reflecting investor concerns over the EPS miss. In analyst updates, Stifel maintained its Buy rating with a price target of $63.00 after a jobsite tour, indicating continued confidence in the company's potential. Meanwhile, D.A. Davidson reiterated a Neutral rating with a $55.00 price target, citing a margin outlook. Despite a revenue beat of approximately 2%, this fell below the company's eight-quarter average of roughly 3%. These developments highlight the varied perspectives and expectations surrounding Procore Technologies in the current market.

Risks

  • Investor concerns over the EPS miss in Q1 2026 have contributed to a decline in the stock price, reflecting market apprehension regarding profitability despite revenue growth.
  • The stock is trading near its 52-week low of $40.74, down significantly from its 52-week high of $82.31, indicating substantial price volatility and potential downward pressure on valuation.
  • The revenue beat of approximately 2% fell below the company's eight-quarter average of roughly 3%, suggesting a potential deceleration in growth momentum that could impact future market expectations.

More from Insider Trading

Big Digital Energy Insiders and 10% Shareholders Execute $498K in Share Purchases Jun 15, 2026 Kingsway CFO Acquires Shares Through ESPP Amid Corporate Restructuring Jun 15, 2026 Ligand Pharmaceuticals Director Jason Haas Offloads $1.65 Million in Shares Amid Earnings Miss and Merger Restructuring Jun 15, 2026 Cadrenal Therapeutics Chairman and CEO Pham Executes $70,351 Stock Sale Under Pre-Arranged Plan Jun 15, 2026 Enovis Executive Purchases Shares Amid Market Volatility and Strong Earnings Jun 15, 2026